1. Singer, A. 1994. News: time and truth for cancer vaccines—a new generation. J. Natl. Cancer Inst. 86: 330–330.
2. Burchell, J., Papadimitriou, J.T., Boshell, M., Gendler, S.J. and Duhig, T. 1989. A short sequence within the amino acid tandem repeat of a cancer-associated mucin, contains immunodominant epitopes. Int. J. Cancer 44: 691–696.
3. Xing, P.X., Prenzoska, J., Quelch, K. and McKenzie, I.F.C. 1992. Second generation anti-MUCI peptide monoclonal antibodies. Cancer Res. 52: 2310–2317.
4. Burchell, J., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, A., Millis, R., and Lamport, D. 1987. Development and characterisation of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47: 5476–5482.
5. Apostolopoulos, V., McKenzie, I.F.C., and Pietersz, G.A. 1996. Breast cancer immunotherapy—current status and future prospects. Immunol. Cell Biol. 74: 457–464.